Rare
lephants
Screener
Toggle theme
MiMedx Group, Inc.
MDXG
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2018
FY2017
FY2016
FY2015
FY2014
Total Cash from Operations:
$85.9M
Line Item
Value
% of Total
Other Investing
$4.6M
5.4%
Stock Repurchases
$58.3M
67.9%
Working Capital
$23.0M
26.7%
Net Cash Flow
$0
0.0%
